HCA Healthcare’s (HCA) “Neutral” Rating Reaffirmed at Robert W. Baird

HCA Healthcare (NYSE:HCA)‘s stock had its “neutral” rating reiterated by equities research analysts at Robert W. Baird in a research report issued to clients and investors on Tuesday, Marketbeat Ratings reports. They currently have a $336.00 price target on the stock, down from their prior price target of $396.00. Robert W. Baird’s target price suggests a potential upside of 1.38% from the stock’s current price.

HCA has been the subject of a number of other reports. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Bank of America reduced their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada dropped their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. Finally, Guggenheim began coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a “neutral” rating on the stock. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $381.67.

HCA Healthcare Stock Down 1.2 %

Shares of NYSE HCA opened at $331.41 on Tuesday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a market capitalization of $81.59 billion, a price-to-earnings ratio of 15.08, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The business has a 50-day moving average of $328.02 and a two-hundred day moving average of $335.60.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the prior year, the firm posted $5.90 earnings per share. On average, analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current fiscal year.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of HCA. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the first quarter worth approximately $28,000. Whipplewood Advisors LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at $31,000. Tidemark LLC acquired a new position in HCA Healthcare in the fourth quarter valued at $36,000. Activest Wealth Management increased its stake in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its holdings in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.